These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9053372)

  • 1. [Interaction of the nervous and immune systems during normal aging and in dementias of the Alzheimer's type].
    Fokin VF; Ponomareva NV; Androsova LV; Selezneva ND
    Fiziol Cheloveka; 1996; 22(6):55-9. PubMed ID: 9053372
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interhemispheric asymmetry and neuroimmune modulation in normal aging and Alzheimer's-type dementias].
    Fokin VF; Ponomareva NV; Androsova LV; Gavrilova SI
    Fiziol Cheloveka; 1997; 23(3):20-4. PubMed ID: 9264942
    [No Abstract]   [Full Text] [Related]  

  • 3. Attentional networks in normal aging and Alzheimer's disease.
    Fernandez-Duque D; Black SE
    Neuropsychology; 2006 Mar; 20(2):133-43. PubMed ID: 16594774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?
    Richartz E; Stransky E; Batra A; Simon P; Lewczuk P; Buchkremer G; Bartels M; Schott K
    J Psychiatr Res; 2005 Sep; 39(5):535-43. PubMed ID: 15992563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Executive function deficits in normal aging, Alzheimer's disease, and frontotemporal dementia].
    Bherer L; Belleville S; Hudon C
    Psychol Neuropsychiatr Vieil; 2004 Sep; 2(3):181-9. PubMed ID: 15689332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of visual evoked potentials alterations in Alzheimer's disease: comparison with normal aging, depression and scopolamine administration in young healthy volunteers.
    Gilles C; De Buyl O; Génévrois C; Salama M; Mendlewicz J
    Acta Neurol Belg; 1989; 89(3-4):226-7. PubMed ID: 2516969
    [No Abstract]   [Full Text] [Related]  

  • 7. Age-related changes of neuro-endocrine-immune interactions in healthy humans.
    Mazzoccoli G; Correra M; Bianco G; De Cata A; Balzanelli M; Giuliani A; Tarquini R
    J Biol Regul Homeost Agents; 1997; 11(4):143-7. PubMed ID: 9582614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of ageing and Alzheimer's disease on semantic and gender priming.
    Manenti R; Repetto C; Bentrovato S; Marcone A; Bates E; Cappa SF
    Brain; 2004 Oct; 127(Pt 10):2299-306. PubMed ID: 15306548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Deficits in inhibitory processes in normal aging and patients with Alzheimer's disease: a review].
    Fournet N; Mosca C; Moreaud O
    Psychol Neuropsychiatr Vieil; 2007 Dec; 5(4):281-94. PubMed ID: 18048106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-specific neuroimmunoendocrine aging in a triple-transgenic 3xTg-AD mouse model for Alzheimer's disease and its relation with longevity.
    Giménez-Llort L; Arranz L; Maté I; De la Fuente M
    Neuroimmunomodulation; 2008; 15(4-6):331-43. PubMed ID: 19047809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The neuroimmune relationships during normal aging and in Alzheimer-type dementias].
    Fokin VF; Ponomareva NV; Androsova LV; Sekirina TP; Koliaskina GI; Gavrilova SI; Selezneva ND
    Vestn Ross Akad Med Nauk; 1996; (4):32-9. PubMed ID: 8754077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third Leonard Berg Symposium: Neurobiology of the Aging Nervous System: introduction.
    Meuser TM
    Alzheimer Dis Assoc Disord; 2003; 17 Suppl 2():S37-8. PubMed ID: 12813204
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].
    Leel-Ossy L; Kindler M; Szucs I; Schwarcz T
    Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of color in the implicit memory performance of healthy older adults and individuals with Alzheimer's disease.
    Lloyd-Jones TJ
    Neuropsychology; 2005 Jan; 19(1):44-53. PubMed ID: 15656762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline.
    Gibbs RB; Aggarwal P
    Horm Behav; 1998 Oct; 34(2):98-111. PubMed ID: 9799621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automatic memory processes in normal ageing and Alzheimer's disease.
    Hudson JM
    Cortex; 2008 Mar; 44(3):345-9. PubMed ID: 18387563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac sympathovagal modulation evaluated by short-term heart interval variability is subtly impaired in Alzheimer's disease.
    de Vilhena Toledo MA; Junqueira LF
    Geriatr Gerontol Int; 2008 Jun; 8(2):109-18. PubMed ID: 18713163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interactions of basic regulating systems (nervous, endocrine and immune) and clinical manifestation of their disturbances].
    Akmaev IG
    Klin Med (Mosk); 1997; 75(11):8-13. PubMed ID: 9490368
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparing source-based and gist-based false recognition in aging and Alzheimer's disease.
    Pierce BH; Sullivan AL; Schacter DL; Budson AE
    Neuropsychology; 2005 Jul; 19(4):411-9. PubMed ID: 16060815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild cognitive impairment: transition between aging and Alzheimer's disease.
    Petersen RC
    Neurologia; 2000 Mar; 15(3):93-101. PubMed ID: 10846869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.